Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| KalVista Pharmaceuticals | 2025 | Post-IPO Debt | Undisclosed | Cambridge |
| Nightfall | 2022 | Series B | Undisclosed | San Francisco |
| Ocelot Bio | 2023 | Debt Financing | Undisclosed | San Diego |
| Arch Data | 2022 | Seed | Undisclosed | Austin |
| Jade Biosciences | 2026 | Post-IPO Equity | Undisclosed | Waltham |
| Pharvaris | 2026 | Post-IPO Equity | Undisclosed | Zug |
| Mahzi Therapeutics | 2025 | Grant | Undisclosed | San Mateo |
| cAMPfield Therapeutics | 2026 | Series A | Undisclosed | San Diego |
| Moment | 2026 | Series C | $36.0M | New York |
| GenLogs | 2026 | Corporate Round | $60.0M | Arlington |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 1 | KalVista Pharmaceuticals | Post-IPO Debt | Undisclosed | Cambridge, United States |
| 2 | Nightfall | Series B | Undisclosed | San Francisco, United States |
| 3 | Ocelot Bio | Debt Financing | Undisclosed | San Diego, United States |
| 4 | Arch Data | Seed | Undisclosed | Austin, United States |
| 5 | Jade Biosciences | Post-IPO Equity | Undisclosed | Waltham, United States |
| 6 | Pharvaris | Post-IPO Equity | Undisclosed | Zug, Switzerland |
| 7 | Mahzi Therapeutics | Grant | Undisclosed | San Mateo, United States |
| 8 | cAMPfield Therapeutics | Series A | Undisclosed | San Diego, United States |
| 9 | Moment | Series C | $36.0M | New York, United States |
| 10 | GenLogs | Corporate Round | $60.0M | Arlington, United States |
KalVista Pharmaceuticals focuses on developing oral medicines, particularly for managing hereditary angioedema.
Nightfall is a cloud data protection platform that uses machine learning to identify and detect business-critical data.
Ocelot Bio brings new treatment options to patients with severe liver disease.
Arch Data is an AI data analytical software that delivers personalized insights and analytics for organizations.
Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications.
Pharvaris is a clinical-stage biomedical company focused on bringing oral bradykinin B2-receptor antagonists to patients.
Mahzi Therapeutics is a health care and biotechnology company.
cAMPfield Therapeutics is a biotechnology company that specializes on exploration and development activities of therapeutic solutions.
Moment develops AI software for investment management and wealth management operations.
GenLogs is a freight intelligence company that offers truck carrier mapping services via AI-driven roadside sensors.
Kelonia Therapeutics develops genetic medicines focused on in vivo gene delivery and cell therapy for cancer and other diseases.
Altruist is a modern custodian that offers a digital investment platform for financial advisors to manage their clients' investments.
Salsify helps brands by providing tools to track and analyze inventories, presentation, and sales of goods on digital shelves.
Quiq is the only enterprise agentic AI platform that IT, CX, and eCommerce leaders can agree on.
GetReal Security is a cybersecurity leader specializing in the detection and mitigation of threats posed by malicious generative AI content.
Decodable is a serverless data integration and engineering platform for streaming data.
Syllo is a legal technology platform
Expedition Therapeutics is a biotechnology company that develops novel therapies for inflammatory and respiratory diseases.
Skyryse is a manufacturing firm that offers aerospace hardware and software operating systems and components design, production, and sales.
Euclid Power delivers software that streamlines renewable energy project development with integrated tools and expertise.
Collate is an AI-powered platform for agentic data intelligence that automates processes and fosters collaboration among data teams.
Zero Networks automates the development and enforcement of network access rules throughout an entire network.
Secure mobile software for mission-critical work: the Adyton Operations Kit is the first & only suite built for the warfighter in mind.
Auditoria is a saas provider of ai-driven cognitive automation to help companies accelerate cash performance and transform the back office.
Enterprise service combining AI and data insights to increase a team's impact
Venrock has invested in 136 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Venrock's top investment sectors include Artificial Intelligence (AI), Software, Biotechnology, Health Care, Biopharma. The firm invests across 55 different industry categories.
Among tracked funding rounds, Skyryse received $167.1M in a Series C round. Venrock's total known invested capital is $3.7B.
Venrock's average investment size is $45.6M across its portfolio of 136 companies.
Recent Venrock portfolio additions include KalVista Pharmaceuticals, Nightfall, Ocelot Bio, Arch Data, Jade Biosciences. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors